HKD 1.77
(-1.12%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 194.33 Million CNY | -68.26% |
2022 | 232.83 Million CNY | 72.25% |
2021 | 135.17 Million CNY | -48.01% |
2020 | 260.01 Million CNY | -9.79% |
2019 | 288.23 Million CNY | -30.88% |
2018 | 417.02 Million CNY | 65.41% |
2017 | 252.11 Million CNY | 133.43% |
2016 | 108 Million CNY | -42.59% |
2015 | 188.12 Million CNY | 33.47% |
2014 | 140.94 Million CNY | 110.82% |
2013 | 66.85 Million CNY | 401.85% |
2012 | 13.32 Million CNY | -83.44% |
2011 | 80.44 Million CNY | 262.81% |
2010 | 22.17 Million CNY | 13.3% |
2009 | 19.57 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 111.78 Million CNY | 0.0% |
2023 Q2 | 122.31 Million CNY | 0.0% |
2023 FY | 73.9 Million CNY | -68.26% |
2023 Q4 | 120 Million CNY | 0.0% |
2022 Q4 | 174.91 Million CNY | 0.0% |
2022 FY | 232.83 Million CNY | 72.25% |
2022 Q2 | 149.42 Million CNY | 0.0% |
2021 FY | 135.17 Million CNY | -48.01% |
2021 Q4 | 14.41 Million CNY | 0.0% |
2021 Q2 | 120.76 Million CNY | 0.0% |
2020 Q2 | 171.78 Million CNY | 0.0% |
2020 Q4 | 88.22 Million CNY | 0.0% |
2020 FY | 260.01 Million CNY | -9.79% |
2019 Q4 | 154.5 Million CNY | 0.0% |
2019 Q2 | 133.73 Million CNY | 0.0% |
2019 FY | 288.23 Million CNY | -30.88% |
2018 FY | 417.02 Million CNY | 65.41% |
2018 Q2 | 220.12 Million CNY | 0.0% |
2018 Q4 | 196.9 Million CNY | 0.0% |
2017 FY | 252.11 Million CNY | 133.43% |
2017 Q2 | 137.55 Million CNY | 0.0% |
2017 Q4 | 114.56 Million CNY | 0.0% |
2016 Q2 | 90.8 Million CNY | 0.0% |
2016 FY | 108 Million CNY | -42.59% |
2016 Q4 | 17.2 Million CNY | 0.0% |
2015 Q4 | 214.38 Million CNY | 0.0% |
2015 FY | 188.12 Million CNY | 33.47% |
2015 Q2 | 26.25 Million CNY | 0.0% |
2014 FY | 140.94 Million CNY | 110.82% |
2014 Q4 | 65.84 Million CNY | 0.0% |
2014 Q2 | 75.1 Million CNY | 0.0% |
2013 Q4 | 47.61 Million CNY | 0.0% |
2013 Q2 | 19.23 Million CNY | 0.0% |
2013 FY | 66.85 Million CNY | 401.85% |
2012 Q1 | -6.89 Million CNY | 0.0% |
2012 Q3 | -6.89 Million CNY | 0.0% |
2012 Q2 | -6.89 Million CNY | 0.0% |
2012 Q4 | 78.12 Million CNY | 1233.1% |
2012 FY | 13.32 Million CNY | -83.44% |
2011 Q4 | -6.89 Million CNY | -1016.52% |
2011 Q2 | 752.25 Thousand CNY | 0.0% |
2011 FY | 80.44 Million CNY | 262.81% |
2011 Q3 | 752.25 Thousand CNY | 0.0% |
2011 Q1 | 752.25 Thousand CNY | 0.0% |
2010 FY | 22.17 Million CNY | 13.3% |
2010 Q3 | -10.85 Million CNY | 0.0% |
2010 Q4 | 752.25 Thousand CNY | 106.93% |
2010 Q1 | -10.85 Million CNY | 0.0% |
2010 Q2 | -10.85 Million CNY | 0.0% |
2009 Q2 | -5.21 Million CNY | 0.0% |
2009 FY | 19.57 Million CNY | 0.0% |
2009 Q3 | -5.21 Million CNY | 0.0% |
2009 Q4 | -10.85 Million CNY | -107.98% |
2009 Q1 | -5.21 Million CNY | 0.0% |
2008 Q4 | -5.21 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 35.87 Million HKD | -441.718% |
Lee & Man Chemical Company Limited | 588.88 Million HKD | 66.999% |